| Symbol | REGMY |
|---|---|
| Name | REMEGEN CO LTD. |
| Sector | UNDEFINED |
| Region | Asia |
| Industry | - |
| Address | |
| Telephone | — |
| Fax | — |
| — | |
| Website | http://www.remegen.com/Default.aspx |
| Incorporation | CN |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | NOT AVAILABLE |
| Reporting Status | International Reporting: Hong Kong Stock Exchange |
| CIK | 0001842625 |
| Description | RemeGen was cofounded in 2008 by Mr. Weidong Wang, founder of Rongchang Pharmaceuticals, a leading traditional Chinese medicine company in China, and Dr. Jianmin Fang, a Canadian-American scientist. Headquartered in the coastal city of Yantai, Shandong Province of China, RemeGen has research labs and offices throughout China and the United States. RemeGen is committed to the discovery, development and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune, oncology and ophthalmic diseases. Additional info from OTC: |
No news found.